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Widely found in animal and plant-associated pro-
teobacteria, type VI secretion systems (T6SSs) are
potentially capable of facilitating diverse interac-
tions with eukaryotes and/or other bacteria. Pseu-
domonas aeruginosa encodes three distinct T6SS
haemolysin coregulated protein (Hcp) secretion
islands (H1, H2, and H3-T6SS), each involved in
different aspects of the bacterium’s interaction with
other organisms. Here we describe the characteriza-
tion of a P. aeruginosa H3-T6SS-dependent phos-
pholipase D effector, PldB, and its three tightly linked
cognate immunity proteins. PldB targets the peri-
plasm of prokaryotic cells and exerts an antibacterial
activity. Surprisingly, PldB also facilitates intracel-
lular invasion of host eukaryotic cells by activation
of the PI3K/Akt pathway, revealing it to be a trans-
kingdom effector. Our findings imply a potentially
widespread T6SS-mediated mechanism, which de-
ploys a single phospholipase effector to influence
both prokaryotic cells and eukaryotic hosts.
INTRODUCTION
Type VI secretion systems have been reported to perform
diverse functions, facilitating interactions both with eukaryotic
hosts and with competing bacterial cells. With the availability
of a large number of bacterial genome sequences, it has become
clear that any given bacterial strain often contains more than one
T6SS-encoding locus. This implies that the T6SS is a versatile
secretion system potentially capable of facilitating a variety of
diverse interactions with eukaryotes and/or with other bacteria
(Jani and Cotter, 2010). For example, Yersinia pestis and
Burkholderia pseudomallei encode four and six T6SS loci,
respectively (Bingle et al., 2008; Boyer et al., 2009). In the
genome of P. aeruginosa, three T6SS loci have been identified:
H1, H2, and H3-T6SS (Mougous et al., 2006).
T6SS effectors identified to date are encoded as either distinct
open reading frames or as C-terminal domains of Valine-Glycine
Repeat protein G (vgrG) genes. They have diverse activities600 Cell Host & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Iincluding peptidoglycan hydrolases, nucleases, and phospholi-
pases. The best-studied examples are Tse1–Tse3, which are
H1-T6SS-dependent antibacterial toxin effectors. Tse1 and
Tse3 have amidase and muramidase activity and act in the
periplasm of target Gram-negative bacteria cells to degrade
the peptidoglycan cell wall (Russell et al., 2011). Tse2 is a cyto-
plasmic effector that acts as a potent inhibitor of target cell pro-
liferation (Li et al., 2012). And an Rhs (rearrangement hotspot)
protein from Dickeya dadantii was shown to be exported by a
T6S system, and its C-terminal domain carries nuclease activity
which degrades target cell DNA (Koskiniemi et al., 2013).
P. aeruginosa also encodes three highly specific cognate immu-
nity proteins, Tsi1–Tsi 3, which are tightly linked to the tse1-3
toxin genes and provide a self-resistance mechanism (Hood
et al., 2010; Russell et al., 2011).
Phospholipase D (PLD) enzymes, which catalyze the hydroly-
sis of phosphodiester bonds, have been identified in viruses,
bacteria, plants, fungi, and mammals (Selvy et al., 2011). PLDs
have been identified as bona fide virulence factors in various
bacteria (Edwards and Apicella, 2006; Jacobs et al., 2010;
Rudolph et al., 1999). Recently, a superfamily of bacterial phos-
pholipase/lipase enzymes has been identified as T6SS lipase ef-
fectors (Tle), which may be classified into five divergent families
(termed Tle1–Tle5). One such effector is a PLD protein, PldA,
which has been confirmed as a substrate for P. aeruginosa
H2-T6SS and exhibits antibacterial activity (Russell et al., 2013).
The phosphatidylinositol 3-kinase (PI3K)/Akt signaling path-
way is crucial to a range of cellular processes including cell
growth, proliferation, and programmed cell death (Krachler
et al., 2011). Akt phosphorylation has been shown to be required
for cellular invasion by a number of bacterial pathogens (Go-
luszko et al., 2008; Kierbel et al., 2005). During P. aeruginosa
invasion of polarized epithelial cells, PI3K becomes activated
and is recruited to the apical cell surface (Engel and Eran, 2011;
Kierbel et al., 2007). Recently, the H2-T6SS of P. aeruginosa
was demonstrated to be involved in PI3K/Akt-dependent
mammalian cell entry, although the relevant substrates involved
in this pathway were not defined (Sana et al., 2012).
An intriguing class of T6SS-dependent exported substrates is
represented by the VgrG proteins, which are often genetically
or functionally linked with T6SS clusters. Initially VgrG proteins
were considered to be only structural components of the T6SS
secretion machinery although the identification of so-called
‘‘evolved’’ VgrG homologs has redefined their role also asnc.
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VgrG-1 has been identified which has a C-terminal actin-cross-
linking domain (Ma et al., 2009; Pukatzki et al., 2006); and
VgrG-3 has a C-terminal domain that can hydrolyze the peptido-
glycan cell wall of Gram-negative bacteria (Dong et al., 2013).
The T6SS apparatus consists of a tube formed by Hcp pro-
teins with VgrG proteins located at the tip. Both proteins have
been shown to be involved in the secretion of T6SS effectors.
It has been reported that the Tse2 effectors interact directly
with the Hcp pore and translocate through the tube during secre-
tion (Silverman et al., 2013). In addition, the VgrG proteins, which
contain C-terminal domains as effectors, can also bind other
effectors during secretion by an as-yet-unknown mechanism
(Dong et al., 2013). Furthermore, proteins belonging to the pro-
line-alanine-alanine-arginine (PAAR) repeat superfamily have
been proposed to be involved in the attachment between
effectors and the T6SS spike complex (Koskiniemi et al., 2013;
Shneider et al., 2013).
Understanding the virulence mechanisms of Pseudomonas
is a high priority and timely, given that Multidrug-resistant
P. aeruginosa was added to the CDC2013 threat report. While
both H2 and H3-T6SSs have been implicated as important
in mediating P. aeruginosa pathogenesis (Lesic et al., 2009),
no substrates for H3-T6SS have yet been established. Here,
we report the identification and characterization of a H3-T6SS-
dependent PLD effector, PldB (PA5089). We demonstrate that
PldB contributes not only to interbacterial competitive fitness
of P. aeruginosa but also to bacterial internalization into human
epithelial cells. Furthermore, we demonstrate that the cell
internalization process is facilitated by PLD-triggered PI3K/Akt
pathway activation. Our findings lead us to propose that the
widely distributed T6S PLD effectors are of importance to under-
standing the virulence ofP. aeruginosa in addition tomore gener-
ally informing on the evolution of specialized bacterial secretion
systems.
RESULTS
PldB Is an H3-T6SS-Dependent Antibacterial Effector
Two PLD-like genes (pldA and pldB) are encoded in the genome
of P. aeruginosa PAO1. PldA is demonstrated as an H2-T6SS-
dependent antibacterial effector by degrading phosphatidyleth-
anolamine (PE) (Russell et al., 2013). However, the function of
PldB is still unclear. Phylogenetic analyses based on two PLD-
conserved regions yielded a tree with four branches, with PldA
and PldB being found in different clades (Figure 1A and see Fig-
ure S1A online). Indeed, PldA is closely related to eukaryotic Pld
and phylogenetically distinct from PldB. This favors a previous
hypothesis that the PldA of P. aeruginosa possibly has a eukary-
otic origin (Wilderman et al., 2001). Although PldA and PldB
might share similar function as phospholipase D, the organiza-
tions of the dual HxKxxxxD catalytic motifs in the two proteins
are distinct (Figure 1B). Since PldA exhibits antibacterial activity,
we asked if PldB could also function as a bacterial toxin. Escher-
ichia coli toxicity assays were performed to test this hypothesis.
As a confirmed antibacterial effector that targets the cell mem-
brane, PldA provided an ideal positive control for these assays.
We noted that, when cytoplasmically expressed, both pldA
and pldB show little toxic effect to E. coli (Figures 1C, S1B,Cell Hand S1D). However, when these PLD proteins were targeted to
the bacterial periplasm using an artificial signal peptide, both
PldA and PldB resulted in a high proportion of growth inhibition
(Figures 1D, S1C, and S1D). Previous observations showed
that PldA’s ability to hydrolyse phosphatidylcholine (PC) is
dependent on a predicted catalytic histidine residue His 855
(Russell et al., 2013). Purified PldB was tested to determine
whether it possesses similar enzymic features as PldA. PldA,
PldB, and two PldB mutants (H305R and H642R) were ex-
pressed as N-terminal maltose binding protein (MBP) fusions
with C-terminal hexahistidine tags. Both mutants showed
decreased PLD activity compared to the wild-type (WT) PldA
and PldB proteins (Figure 1E). Further, to test whether the
two catalytic motifs of PldB contribute to its bacterial toxicity,
membrane permeability was assayed for E. coli strains express-
ing (periplasmically) pldB, the two pldB mutants (H305R or
H642R), or pldB with its cognate immunity genes. Our results
demonstrated that mutation of either of the catalytic residues
or coexpression with the immunity proteins decreased PldB-
dependent membrane permeability of E. coli (Figure 1F).
The H1 and H2-T6SSs of P. aeruginosa both facilitate their in-
terbacterial toxic activities in a cell-cell contact manner (Russell
et al., 2011, 2013). Interestingly, while the H1-T6SS effectors are
encoded by multiple P. aeruginosa strains, the H2-T6SS effector
gene pldA appears to have been acquired by a more recent hor-
izontal gene transfer event (Wilderman et al., 2001). This is also
true of the loci encoding pldB (Figure 2A), suggesting that
it may also be an H1-T6SS-independent substrate. Similar hori-
zontal acquisition or genetic deletion events appear also to have
occurred in many other strains for the Tle-family effectors (Fig-
ure S2). Quantitative RT-PCR analysis of P. aeruginosa PAO1
in the prolonged static culture at 37C indicated that pldB
expression is upregulated at the same time as the H3-T6SS
locus (Figure S3A), further supporting the suggestion that it rep-
resents a substrate for H3-T6SS. Intra- and interbacterial growth
competition assays were performed under these conditions,
with several P. aeruginosa mutants and the T6SS target bacte-
rium model, P. putida. First, we constructed mutant strains
of clpV1-3, bearing deletion of the three ATPase genes vital for
H1-3 T6SS functions, respectively. Intrabacterial competition
assays between P. aeruginosa strains at 37C for 48 hr showed
that the ablation of H3-T6SS or PldB function, but not H1 or H2-
T6SS, abolished bacterial toxicity, reducing the normal growth
advantage (Figure 2B). Further, interbacterial competition as-
says between P. aeruginosa and P. putida confirmed that knock-
ing out pldB also reduced the growth advantage to the same
extent as the H3-T6SS clpV3mutant under H3-T6SS-conducive
conditions (37C, 24 hr, Figure 2C). Note that the growth advan-
tage could be restored to either the pldB or clpV3 knockout
strains by transcomplementation with a functional pldB or
clpV3 gene, respectively. These results demonstrate that PldB
is an effective H3-T6SS-dependent antibacterial toxin.
All Three Immunity ProteinsCan Inhibit PldB-Dependent
Antibacterial Activity
Typically T6SS effector immunity proteins are genetically tightly
linked to their cognate toxins in a 1:1 ratio. For example, the
PA3488 gene encoded immediately downstream of pldA acts
as immunity determinant of PldA (Russell et al., 2013). Sinceost & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Inc. 601
Figure 1. PldB Encodes Two Conserved Catalytic Motifs and Is Toxic to E. coli when Targeted to the Periplasm
(A) Phylogeny of 97 PLD proteins from various bacterial/eukaryotic species. Bootstrap values for the main branches are shown.
(B) Organization of catalytic motifs in PldA, PldB, and a knownN. gonorrhoeae PLD virulence factor (regions comprising the catalytic motifs are labeled in red, and
positions of conserved residue-H are denoted).
(C and D) Growth of E. coli strain BL21 (DE3) pLysS containing pET28 a(+) (C) or pET22 b(+) (D) expressing pldA/B on LB agar with 0.25 mM IPTG at 37C. An
empty vector was included as control. Ten-fold serial dilution of overnight culture was spotted onto LB medium plates from left to right.
(E) Phospholipase D activity assay. PLD activity of indicated proteins was determined bymeasuring the production of choline from phosphatidylcholine using the
Amplex Red assay kit (Invitrogen) as described previously (Jacobs et al., 2010).
(F) Membrane permeability of E. coli strains expressing indicated proteins in pET22 b(+) after 2 hr induction as measured by P.I. staining. pldB-5086, pET22
expressing operon from PA5089 to PA5086. Unrelated P. aeruginosa cytosolic protein Vfr as negative control. a.u., arbitrary units.
Error bars represent ± SEM (n = 3); **p < 0.05. See also Figure S1.
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A T6S PLD Protein Is Trans-Kingdom EffectorPldB is active in the bacterial periplasm, we speculated that its
immunity protein(s) should encode N-terminal signal peptides.
Interestingly, downstream of pldB, three open reading frames
(ORFs), PA5088, PA5087, and PA5086, are homologs with high
identity (more than 80%), with predicted signal peptides (Fig-
ure S4A), suggesting that they are targeted to the periplasm
(Figure S4B).
We tested whether PA5088, PA5087, and PA5086 encode
immunity proteins for PldB. We constructed three expression
plasmids which harbored the pldB gene alone and pldB with
one (PA5088) or three (PA5088–PA5086) putative immunity pro-
tein genes for heterologous expression in the E. coli BL21 (DE3)
pLysS strain. In all cases we translationally fused the pldB gene
to a signal peptide to ensure targeting of the PldB protein into
the periplasm. Figure 3A shows that the growth inhibition to
the E. coli strain caused by the expression of pldB alone was
decreased by an order of magnitude when it was coexpressed
with PA5088. Coexpression of all three putative immunity pro-602 Cell Host & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Iteins further decreased growth inhibition by another order of
magnitude, indicating a dose-dependent additive protective
effect of these immunity proteins.
To determine if the immunity proteins could physically interact
with PldB, we performed coimmunoprecipitation studies using
E. coli in which FLAG-tagged PldB was coexpressed with
Myc-tagged immunity proteins. Western blot analysis confirmed
that all three immunity proteins can specifically bind to PldB (Fig-
ure 3B). Moreover, the immunity protein for PldA (PA3488) does
not bind to PldB, and vice versa (Figure S4C). This indicates
specificity of these immunity proteins for their cognate toxin
effectors.
Growth competition assays were performed to verify if these
three immunity proteins were able to rescue a fitness defect in
a strain of P. aeruginosa in which the pldB and the immunity pro-
teins had been deleted (DPA5089–DPA5086). Complementation
of any of these three immunity proteins enabled themutant strain
to compensate for the growth disadvantage against the WTnc.
Figure 2. PldB Is an H3-T6SS-Dependent Antibacterial Effector
(A) Genomic evidence suggesting that the VgrG-lipase-immunity protein cassettes encoding PldA (H2-T6SS substrate) or PldB have been horizontally acquired or
deleted.
(B) Intrastrain P. aeruginosa growth competition assays between the indicated donor strains (x axis) following coculture with recipient strain under H3-T6SS-
conducive conditions (prolonged static growth at 37C for 48 hr). The recipient strain is P. aeruginosa in which pldB and three putative immunity protein genes
have been deleted (DPA5089-5086); *p < 0.01.
(C) Competitive growth outcome of the indicated P. aeruginosa donor strains (x axis) against P. putida recipient strain at 37C for 24 hr. The competitive index
result is calculated as the final c.f.u. ratio (donor/recipient) divided by the initial ratio. Error bars represent ± SEM (n = 3). **p < 0.05. See also Figures S2 and S3.
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that PA5088, PA5087, and PA5086 can all function as immunity
proteins against PldB toxicity.
PLD Enzymic Activities of PldA and PldB Contribute to
the Internalization of P. aeruginosa into Human
Epithelial Cells
To address the potential role of PldB in P. aeruginosa internaliza-
tion, we constructed several nonpolar mutant strains for testing
bacterial invasion into adherent HeLa cells. It has been previ-
ously shown that H2-T6SS contributes to P. aeruginosa internal-
ization into human epithelial cells during exponential phases
(Sana et al., 2012). We therefore first tested a panel of single-
loci mutants grown at this phase for their ability to be internalized
into cultured cells. Although epithelial invasion of the mutant
defective in H2-T6SS (DclpV2) decreased compared with WT
strain as previously reported (Sana et al., 2012), mutants defec-
tive in H1-T6SS (DclpV1), H3-T6SS (DclpV3), or pldB (DpldB)Cell Hinternalized at the same level as WT strain (Figure 4A), suggest-
ing that they are not involved in the invasion by cells growing in
exponential phase.
Given that H3-T6SS and pldB are both coupregulated during
stationary phase (Figure S3B), we tested single and double mu-
tants grown at stationary phase. As the invasion efficiency of the
H1-T6SSmutant (DclpV1) showed no difference to that of theWT
at this phase (Figure 4B), it is clear that H1-T6SS is not involved
in internalization. As single knockouts of either pldB, H2, or H3-
T6SS showed no decrease in invasion efficiency (Figure 4B), we
used DclpV2 as the parental strain to construct two double
knockout strains (DclpV2&V3 and DpldB&V2). Importantly, the
invasion efficiency of DpldB&V2 (a double knockout of the
H2-T6SS function and the potential H3-T6SS effector-PldB)
decreased significantly, which is similar to the result obtained us-
ing DclpV2&V3 (a double knockout of both the H2 and H3-T6SS
functions) (Figure 4B). The complementation of the DpldB&V2
mutant with PldB restored the invasion phenotype (Figure 4C).ost & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Inc. 603
Figure 3. Three Cognate Immunity Protein Genes Are Encoded Downstream of pldB, which Block PldB Induced Antibacterial Activity
(A) Expression of pldB in pET22 b(+) with a PelB signal peptide only or with either one (PA5088) to three putative immunity protein genes (PA5088-PA5086) in
E. coli BL21 (DE3) pLysS. Empty vector was included as control. Ten-fold serial dilution of overnight culture was spotted on LB agar plates with 0.25 mM IPTG
from left to right.
(B) PldB interacts directly with three immunity proteins. FLAG-tagged PldB and Myc-tagged immunity protein are coexpressed in E. coli BL21 (DE3) pLysS. Cell
lysates were incubated with anti-FLAG antibody-magnetic beads, and bound proteins (IP) were eluted and detected. Note that the arrow indicates smaller
isoforms of the three immunity proteins that are consistent with cleavage of the predicted signal peptides.
(C) Growth competition confirms that PA5088, PA5087, and PA5086 are PldB immunity proteins under H3-T6SS-conducive conditions (prolonged static growth
at 37C for 48 hr). The recipient P. aeruginosa strains are the mutant of the whole pldB-immunity gene locus (DPA5089-5086) with different complemented
immunity gene as indicated. The donor strain is the WT PAO1. Recipient to donor ratio of complemented strains was normalized to empty vector. Error bars
represent ± SEM (n = 3); *p < 0.01. See also Figure S4.
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A T6S PLD Protein Is Trans-Kingdom EffectorThis implies that PldB secretion is dependent upon H3-T6SS
and not H2-T6SS. Based on these findings and the previous
competition assay results (Figures 2B and 2C), we conclude
that PldB is an H3-T6SS-dependent effector. In a similar manner
we demonstrated that the DpldA&V3 (a double knockout of the
H3-T6SS function and the H2-T6SS effector-PldA) showed a
similar decrease in invasion efficiency when compared to the
DclpV2&V3 mutant (Figure 4B), confirming that PldA is an H2-
T6SS-dependent effector.
We next tested whether the catalytic motifs of PldA and PldB,
which play crucial roles in bacterial toxicity, are required for
the cell invasion process. We noted the invasion efficiency of
the DpldB&V2 mutant (which still retains a functional H3-T6SS)
was restored to WT levels when complemented with WT PldB,
but not with a version of PldB in which important catalytic resi-
dues had been mutated (Figure 4C). Equivalent results were
seenwith similar experiments using theDpldA&V3mutant (which
retains a functional H2-T6SS) complemented with either a WT or604 Cell Host & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Imutant pldA gene (Figure 4C). These findings imply that the
PLD activities of PldA and PldB, both of which would generate
phosphatidic acid (PA), are important in contributing to the
P. aeruginosa invasion phenotype.
Cytotoxicity assays under the same conditions used for the
HeLa cell invasion studies demonstrated that neither PldA
nor PldB promoted any cytotoxicity (Figure S5A). Furthermore,
bacterial adhesion and survival assays showed no difference
between theWT andmutant strains (Figures S5B and S5C), sup-
porting the suggestion of a specific function for PldA/B in cellular
internalization.
Finally, we explored the invasion of P. aeruginosa strains into a
more physiologically relevant cell line, human alveolar epithelial
cells (A549). Similar bacterial invasion results were obtained as
observed in the HeLa cell assays (Figure 4D). Based on these
findings we conclude that PldA and PldB contribute to internali-
zation in human epithelial cells in a PLD activity-dependent
manner.nc.
Figure 4. PLD Effectors Are Involved in
Internalization of Human Epithelial Cells
(A) Invasion assays in HeLa cells infected with the
indicated P. aeruginosa strains grown at expo-
nential phase. H2-T6SS is involved in invading
HeLa cells during exponential phase as previously
reported (Sana et al., 2012), but H3-T6SS is not
active at this phase. The percent invasion of indi-
cated strains is normalized to the WT PAO1.
(B) Invasion assays inHeLacells upon infectionwith
the indicated P. aeruginosa strains grown at sta-
tionary phase. The percent invasion of indicated
strains is normalized to the WT. The invasion effi-
ciency of DclpV2&V3 (H2 and H3-T6SS double
mutant), DpldA&V3 (mutant deplete of H3-T6SS
and one H2-T6SS effector), DpldB&V2 (mutant
depleteofH2-T6SSandoneH3-T6SSeffector), and
DpldA&pldB (mutant deplete of PldA and PldB ef-
fectors) decreased significantly comparedwithWT.
(C) Complementation invasion assay confirms that
the PLD activity of PldB or PldA contributes to HeLa
cells’ invasion. All strains were grown at stationary
phase. Invasion efficiency of DpldB&V2 mutant
containing vector control, pldB, or pldB mutated
at the two conserved catalytic motifs (H305R or
H642R), and DpldA&V3 mutant containing pldA or
pldA mutated at the catalytic motif (H855R) are
indicated.
(D) A more physiologically relevant cell line, hu-
man alveolar epithelial cell A549, was used for
bacterial invasion assays with indicated stationary
phase strains.
All error bars represent ± SEM (n = 3); *p < 0.01.
See also Figures S3 and S5.
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Cells
Translocation of PldA/B into HeLa cells was determined by using
a TEM-1 b-lactamase fusion PLD (PLD-Bla) and CCF2-AM.
CCF2-AM is a FRET substrate that can accumulate in host cells.
In the absence of b-lactamase it emits green fluorescence, while
in the presence of b-lactamase it can be cleaved and produces
blue fluorescence (Ma et al., 2009). Cells infected with PAO1
strain expressing the PldB-Bla protein displayed higher blue/
green fluorescence ratio than those infected with the WT strain,
which lacks the TEM-1 fusion protein. However, incubation with
the H3-T6SS mutant reduced the fluorescence ratio to a similar
level to that of the WT strain. In a similar way we demonstrated
that infection with a strain expressing PldA-Bla had a high fluo-
rescence ratio, while incubation with the H2-T6SS mutant again
displayed a lower ratio (Figure 5A). Fluorescence microscopy
imaging illustrated that the cells became blue when exposed
to strains containing PldA-Bla or PldB-Bla, but remained green
with either of the H2/3-T6SS mutants (Figure 5B). This supports
the cytosolic translocation of PldA and PldB are dependent on
H2 or H3-T6SS, respectively.
PldA and PldB Activate the PI3K/Akt Pathway during
P. aeruginosa Infection
The eukaryotic PI3K/Akt signaling pathway has been shown
to play an essential role in the epithelial cell invasion of
P. aeruginosa (Kierbel et al., 2005). The activation of PI3K and
subsequent Akt phosphorylation has been demonstrated to beCell HH2-T6SS dependent (Sana et al., 2012). To test the role of
PldB in this pathway, a PI3K-specific inhibitor, LY294002, was
used to test the link between the PLD protein and the PI3K/
Akt pathway. Internalization assays demonstrated that the
DclpV2 and DclpV3 mutants presented similar invasion effi-
ciencies as the WT strain. As expected, the PI3K inhibitor
LY294002 abolished epithelial invasion by either the WT strain
or the PldB transcomplemented DpldB&V2 mutant strain in a
dose-dependent manner (Figure 6A). These results suggested
that PI3K/Akt pathway is required for the H3-T6SS-dependent
internalization. Nevertheless, bacterial adhesion to monolayers
was not affected by the LY294002 treatment (data not shown),
indicating that the PI3K/Akt pathway has no role in this bacterial
phenotype. To further verify whether PldA and PldB are involved
in the process of PI3K/Akt activation, the status of Akt
phosphorylation at serine 473 was determined by western
blot. Cultured HeLa cells were infected with the PAO1WT strain,
and the double mutants:DclpV2&V3,DpldA&V3, andDpldB&V2.
Cell lysates were then immunoblotted and probed for total
and phosphorylated Akt, respectively. Phosphorylation of Akt
was notably reduced in cells that had been infected with the
DclpV2&V3, DpldA&V3, and DpldB&V2 mutants compared
with the WT strain (Figure 6B). We note that the complemented
mutant strains, DpldB&V2 with PldB and DpldA&V3 with PldA,
restored Akt activation to the levels induced by the WT PAO1
(Figure 6B). These findings demonstrate that PldA and PldB
are involved in the activation of PI3K/Akt signal pathway during
P. aeruginosa invasion.ost & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Inc. 605
Figure 5. Translocation of PldA-Bla or
PldB-Bla into HeLa Cells
(A) Secretion of PLD-Bla fusion proteins into HeLa
cells. Cells were infected with the indicated PAO1
strains expressing TEM-1 fused PldA or PldB at a
moi of 100 for 3 hr. After infection, cells were
loaded with CCF2-AM. Values are quantified by
the emission ratio of blue (cleaved, 460 nm) and
green (uncleaved, 530 nm) fluorescence and
normalized to mock. Error bars represent ± SEM
(n = 3).
(B) Visualization of the translocation of PLD ef-
fectors by using fluorescence microscopy. In-
fected cells were loaded with CCF2-AM. Green
cells contain intact CCF2-AM, whereas blue cells
contain cleaved CCF2-AM, indicating the trans-
located PLD-Bla fusion proteins. Scale bar, 10 mm.
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A T6S PLD Protein Is Trans-Kingdom EffectorPrevious work has indicated that the N. gonorrhoeae PLD can
interact directly with Akt kinase (Edwards and Apicella, 2006).
We therefore tested if PldA and PldB could also bind to the Akt
kinase, using a PLD-Akt pull-down assay. As anticipated, MBP
fusions of both PldA and PldB were shown to bind Akt immune
complexes (Figure 6C). As negative controls we confirmed that
neither the MBP protein alone nor the unrelated P. aeruginosa
T3SS phopholipase ExoU binds to Akt kinase (Figures 6C and
S6A). The binding of the PldA and PldB to Akt was confirmed
by performing the converse experiments in which Akt could be
detected in complex withMBP-PLD that had been isolated using
anti-MBP conjugated magnetic beads (Figure 6D). To determine
which specific Akt-kinase these effectors were binding to, we
used three different antibodies with specificities to Akt1, Akt2,
or Atk3. In these pull-down assays we were only able to detect
the Akt1 and 2 proteins, implying that PldA and PldB could not
bind to Akt3 (Figure 6D). Interestingly, pull-down assays with
PldA and PldB inactivated mutants showed that PLD activity
was not required for binding to Akt (Figure S6B).Moreover, coex-
pression of PldA or PldB with Akt1 directly in HeLa cells showed
that they colocalized close to the plasma membrane (Figure 6E),
and that neither PldA nor PldB exhibited any cytotoxicity to
eukaryotic cell when expressed directly in HeLa (Figures S6C
and S6D). These results suggest that a PLD-Akt complex forms
during the P. aeruginosa infection.
DISCUSSION
Bacterial secretion systems can specifically recognize and
release a distinct subset of substrates to the cell surface, the
extracellular milieu, or directly translocate proteins into host cells
(Gala´n, 2009; Izore´ et al., 2011). For example, P. aeruginosa
T3SS translocates a specific phospholipase effector, ExoU,
which exhibits toxicity in the host cell (Dean, 2011). For the
H1-T6SS of P. aeruginosa, several effectors have been shown
to be bacteriolytic enzymes that degrade the peptidoglycan of
adjacent prokaryotic cells (Hood et al., 2010; Russell et al.,
2011). Here, we present the identification of a P. aeruginosa
H3-T6SS-dependent trans-kingdom effector, PldB. While PldA,
a eukaryotic-like PLD antibacterial protein, was previously
shown to be secreted via the H2-T6SS (Russell et al., 2013),606 Cell Host & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Iwe demonstrate here its additional role in eukaryotic cell inva-
sion. This is of particular importance to understanding the viru-
lence of P. aeruginosa as we show PLD activity is pivotal for
not only antibacterial toxicity but also the ability to invade human
epithelial cells. It is likely that the same T6SS-elaborated intercel-
lular channel or bridge that is used to translocate effectors into
adjacent bacterial cells (Basler et al., 2012) is also used to trans-
locate the PLD effectors into eukaryotic cells.
A common feature of T6SS antibacterial effectors is the tight
linkage of immunity protein genes which confer self-immunity.
An alignment of the three confirmed PldB immunity proteins
shows they are close homologs, possible generated through
gene duplication (Figure S4A). All three homologs appear to
function equally well in protecting against PldB toxicity, and
contribute to resistance in a dose-dependent manner, suggest-
ing a comparable blocking mechanism. Considering that many
other pldB homologous loci also encode more than one immu-
nity protein (Figure S4D), it remains possible that ‘‘stockpiling’’
a range of immunity proteins may serve to protect against similar
effector proteins from related species, which would otherwise
pose a threat. It is interesting to note the clear role of PldB in
growth competition, under conditions which are different from
that of H2-T6SS-dependent PldA secretion (prolonged incuba-
tion at 37C for PldB and SCFM media 23C for PldA).
P. aeruginosa is known to colonize the lungs of cystic fibrosis
(CF) patients in stagnant mucus secretions which are depleted
in oxygen (Worlitzsch et al., 2002). Previous transcriptome
analyses have indicated that pldB and H3-T6SS loci are both
upregulated under low-oxygen conditions (Alvarez-Ortega and
Harwood, 2007) and also during biofilm formation (Do¨tsch
et al., 2012). Induction of PldB and H3-T6SS in these conditions
may allow better colonization of the lung epithelium through
invasion. Furthermore, given that P. aeruginosa is found within
polyclonal and polymicrobial biofilms in the lung (Sibley et al.,
2006; Singh et al., 2000), we may speculate that PldB also pro-
vides a competitive advantage in the harsh environment of a
long-term CF infection.
The Hcp and VgrG proteins have both been shown to play a
role in the export of T6SS effectors (Basler et al., 2012; Shneider
et al., 2013). Recently, Hcp1 in P. aeruginosa PAO1 has been re-
ported as a chaperone and receptor for theH1-T6SS secretion ofnc.
Figure 6. PI3K/Akt Activation Is Associated with H2 and H3-T6SS during P. aeruginosa Invasion
(A) The percentage of PAO1mutants (DclpV2,DclpV3,DpldB&V2, and complementedDpldB&V2) invasion normalized to theWT strain. The cells were pretreated
with different concentrations (0, 10 and 50 mM) of PI3K inhibitor, LY294002, for 1 hr prior to infection with various stationary phase bacteria as in Figure 4B. A total
of 0 mM LY294002 indicates only solvent DMSO was added. The assays were performed in triplicates. Error bars represent ± SEM (n = 3).
(B) Shown are levels of total (T-Akt) and phophorylated (P-Akt) Akt in HeLa cells infected with indicated stationary phase strains for 3 hr. GAPDH is included to
provide a control for sample quality and loading amount.
(C and D) Pull-down assays between Akt and PLD proteins. (C) HeLa cell lysate was incubated with purified MBP or MBP-PLD proteins and then with Akt
antibody-conjugated magnetic beads. Immunoprecipitation was conducted by blotting with anti-MBP or anti-total Akt antibody. Note that MBP protein alone
cannot bind to the Akt kinase. (D) Cell lysate and PLD protein mixtures were incubated with anti-MBPmagnetic beads, and a similar procedure was performed as
described in (C) with anti-total Akt or anti-Akt1/2/3 antibody.
(E) FLAG-tagged Akt1 (green) and His-tagged PldA or PldB (red) were transiently coexpressed in HeLa cells. Nuclei were stained with DAPI (blue). Colocalization
of Akt1 with PldA (left) or PldB (right) was monitored by immunofluorescence microscopy (yellow, white arrows).
See also Figure S6.
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rings (Silverman et al., 2013). Hcp forms homohexameric rings
which stack to form tubular structures (4 nm in diameter) with
VgrG localized at the tip (Basler et al., 2012). It is predicted
that PldA (122.3 kDa) and PldB (83.4 kDa) proteins would be
too large to be transported through the Hcp tube unless they
are in an unfolded state or have an elongated conformation.
An alternative mechanism has been proposed in which effector
transport does not require transit through the Hcp tube (Shneider
et al., 2013). Five hcp and ten vgrG genes are encoded in the
genome of P. aeruginosa PAO1 (Barret et al., 2011), and our
coimmunoprecipitation and bacterial two-hybrid assays support
this hypothesis in that although neither PldA nor PldB bind to
any of the Hcp proteins (Figure S7), they can directly interact
with VgrG proteins. Unfortunately, little binding specificity was
observed (Figure S7), potentially due to the interference ofCell Hin vitro buffer conditions to noncovalent binding between these
proteins. It is still possible that the precise T6SS substrate
selection mechanism is more complex than the straightforward
Hcp/VgrG-substrate interactions we have tested here. Indeed,
in Agrobacterium tumefaciens Hcp interacts directly with VgrG-
1 (Lin et al., 2013).
PI3K/Akt activation is a common mechanism that intracellular
pathogens use to invade host cells. During the intracellular inva-
sion processes of Listeria monocytogenes (Sidhu et al., 2005)
andHelicobacter pylori (Allen et al., 2005), PI3K is activated spe-
cifically at the site of bacterial aggregation on the cell surface for
Akt phosphorylation. A similar phenomenon has been observed
in P. aeruginosa invasion (Kierbel et al., 2007), suggesting an
analogous mechanism for cellular entry of this pathogen. Unlike
the observation in N. gonorrhoeae, which demonstrated that
NgPLD augments epithelial invasion by interacting with Aktost & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Inc. 607
Figure 7. Schematic Model of Three T6SS
Functions in P. aeruginosa
H1-T6SS contributes to a prokaryotic growth
advantage and delivers effectors into the peri-
plasm or cytoplasm of recipient bacterial cells. H2
and H3-T6SS target both prokaryotic and eu-
karyotic cells. For prokaryotic cells, H2/3-T6SS
substrates, PldA/PldB, are translocated into the
periplasm of recipient cells. For eukaryotic cells,
PldA/PldB activate PI3K/Akt pathway for the
subsequent actin rearrangement and protrusion
formation, which facilitate the internalization of
P. aeruginosa into host cell. PA, phosphatidic acid.
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natural Akt ligand, Ptdlns(3,4,5)P3 (phosphatidylinositol 3,4,5-tri-
sphosphate), for Akt binding, our findings showed that PLD-
induced cell invasion in P. aeruginosa is PI3K dependent and
that its activity is critical for the cell invasion process, as mutants
in the conserved catalytic motifs cannot complement the inva-
sion defects in the knockout strain. Also, this PLD activity is
not related to Akt binding. This is consistent with findings that
implicate phosphatidic acid, a product of PLD activity degrading
themajor components of cellular membrane PC (Figure 1E) or PE
(Russell et al., 2013), in the positive regulation of Akt phosphor-
ylation (Toschi et al., 2009).
Since PLD from other bacteria can bind Akt and facilitate its
translocation to membrane ruffles where it becomes phosphor-
ylated (Edwards and Apicella, 2006), we may speculate that
the interaction of PldA/B-Akt could induce a similar effect. More-
over, our results demonstrated that PldA/B can interact with Akt1
and Akt2, but not Akt3. Akt1/2 has been proven to play a role in
the regulation of palladin activity, which modulates actin cyto-
skeletal organization (Chin and Toker, 2010a, 2010b). As protru-
sion formation following actin rearrangement was considered to
benefit bacterial entry of epithelial cells (Engel and Eran, 2011),
we therefore proposed a model in which PLD-induced Akt acti-
vation results in actin rearrangement and membrane protrusion
on the apical surface which facilitates P. aeruginosa internaliza-
tion (Figure 7). Although the detailed mechanism of PLD-depen-
dent Akt activation remains unclear, our demonstration of the
involvement of H2/3-T6SS secreted substrates is important for
understanding how P. aeruginosa gains entry into epithelial cells.
The H2/3-T6SS loci have been shown to be essential
P. aeruginosa mammalian virulence factors (Lesic et al., 2009).
In this study we have unraveled the importance of the two H2/
3-T6SS-dependent PLD effectors, PldA and PldB, in the process
of the killing of bacterial competitors and for internalization into
human epithelial cells. The lack of homology between PldA
and PldB suggests they have developed similar functions by
convergent evolution. This would suggest a highly selected trait
and critical role for their activities regarding virulence and sur-608 Cell Host & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Inc.vival of the bacterium in the mamma-
lian host. Interestingly, TseL, which is
a V. cholerae T6SS lipase effector, was
also shown to be required for killing
D. discoideum amoebae (Dong et al.,
2013). As type VI lipase effectors arewidely distributed in diverse bacterial pathogens, including
Vibrio, Burkholderia, and Pseudomonas, their interactions with
a range of different eukaryotic cells may be expected. Finally,
these PLD-like effectors may also represent exciting targets for
antimicrobial drug development for combating chronic infec-
tions such as those in CF patients.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Growth Conditions, and Plasmids
All bacterial strains and plasmids used in this study are listed in Table S1. De-
tails of growth conditions and strain and plasmid constructions are described
in Supplemental Experimental Procedures.
E. coli Toxicity and Membrane Permeability Assays
Overnight cultures of E. coli strain BL21 (DE3) pLysS containing pET28 a(+)
or pET22 b(+) expressing cytoplasmic or periplasmic targeted proteins were
serially diluted in LB medium at 10-fold. A total of 5 ml of this bacterial dilution
was spotted on LB agar containing 0.25 mM IPTG. Pictures were taken after
16–24 hr growth. E. coli strains harboring pET22 b(+) derivatives encoding
both effector and immunity proteins were performed in a similar way. For
membrane permeability assay, overnight cultures were diluted and pregrown
for 2 hr, and then induced with 0.1 mM IPTG for 2 hr. Cells were stained with
1.5 mM propidium iodide (P.I.) in PBS for 15 min, and fluorescence was
measured at 535/617 nm (excitation/emission). Data were normalized to the
cell density as measured by OD600.
Growth Competition Assays
Intra- and interspecies competition assays were conducted as described in
Supplemental Experimental Procedures. For P. aeruginosa-P. putida compe-
tition, the initial donor-recipient ratio was 1:1 (OD600 of 3.0 for each strain) and
incubation for 24 hr at 37C (a condition shown to induce transcriptional
co-upregulation of H3-T6SS and pldB, P. putida harbored pBBR1MCS5 for
gentamycin selection). For P. aeruginosa-P. aeruginosa competition, the initial
ratio was 5:1 (OD600 of 1.0 for donor strain and OD600 of 0.2 for recipient strain)
and incubation for 48 hr at 37C (a condition shown to induce transcriptional
co-upregulation of H3-T6SS and pldB).
Coimmunoprecipitation and Western Blot Analysis
FLAG-tagged PLD proteins in pME6032 and Myc-tagged Hcps, VgrGs, or im-
munity proteins in pBAD/Myc-His A were coexpressed in E. coli. Cell lysates
were incubated with 50 ml anti-FLAG or anti-Myc magnetic beads (MBL) at
4C for 2 hr. Beads were washed three times with Tris-buffered saline (TBS),
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A T6S PLD Protein Is Trans-Kingdom Effectorand bound proteins (IP) were eluted for western blot analysis. Full details are in
Supplemental Experimental Procedures.
PLD Protein Purification and Phospholipase D Activity Assay
PldA, PldB, and its mutants were fused with 30 His tag and purified using
nickel affinity chromatography (Amersham). For full details of purification,
see Supplemental Experimental Procedures. Purified PLD protein was used
at 400 nM for the Phospholipase D activity assay at 37C for 2 hr by using
the Amplex Red assay kit (Invitrogen). All measured fluorescent values were
normalized against a buffer-only control.
Cell Invasion Assays
HeLa or A549 cell lines were cultured in Dulbecco’s modified Eagle’s medium
(DMEM, Thermo Scientific) supplemented with 10% fetal bovine serum (FBS)
and streptomycin-penicillin (Invitrogen) as needed in 12-well plates. Cell cul-
tures were grown to 70% confluence at 37C (under 5% CO2) before washing
with sterile PBS. After infection with P. aeruginosa (WT or mutant strains) from
either exponential (OD600 0.5–0.8) or stationary phase (OD600 3.0–4.0) at a
multiplicity of infection (moi) of 50 (if needed, 0.1 mM IPTG was added for
induction), the tissue culture plates were centrifuged for 5 min at 1,000 g.
Following a 3 hr infection the cells were washed twice with PBS before incuba-
tion in DMEM containing 200 mg/ml gentamycin at 37C for 2 hr. Finally, the
cells were washed with PBS three times before lysis with ddH2O containing
0.1% Triton X-100 on ice for 30 min. After serial dilution, colony-forming units
(CFUs) were counted to determine the number of internalized bacteria in the
epithelial cells. Inhibitor experiments were carried out as above except that
cells were preincubated with DMEM containing LY294002 (Cell Signaling
Technology, CST) for 1 hr.
Translocation Assay for PLD::TEM-1 Fusions
HeLa cells were grown in 96-well plates to 70% confluence as described
above. After two washes with PBS the cells were infected with bacterial strains
expressing TEM-1 fusion PLDs (at a moi of 100) for 3 hr. Host cells were then
washed with HBSS and treated with CCF2-AM (Invitrogen) for 90 min at room
temperature. Fluorescence was quantified using a microtiter plate reader at
an excitation of 405 nm according to the manufacturer’s instructions. Translo-
cation was demonstrated as a ratio of cleaved (460 nm, blue) to uncleaved
(530 nm, green) signal. For microscopic observation, samples were examined
with a Nikon fluorescence microscope.
Statistical Analysis
Two sample t test comparisons were used to confirm statistical significance at
95%confidence between the two samples compared; *p < 0.01 and **p < 0.05.
Akt Immunoblotting and Pull-Down Assay
HeLa cells grown in 6-well plates were infected with stationary phase bacteria
for 1 hr at a moi of 100 at 37C. The epithelial cells were washed with cold PBS
twice and then lysed with 300 ml RIPA buffer (CST) supplemented with prote-
ase and phosphatase inhibitor cocktail (Roche) on ice for 30 min. After that,
cells were scraped off and centrifuged at 14,000 rpm for 15 min. The superna-
tant was collected and the protein concentration was determined by Bradford
reagent (Sigma). Approximately 40 mg lysate was boiled in SDS-PAGE loading
buffer, and western blot was performed. For Akt-PLD pull-down assay, HeLa
cell crude lysate and purified PLD or MBP (New England Biolabs) proteins
were mixed and incubated with anti-MBP magnetic beads (New England Bio-
labs) or AktmousemAb (magnetic bead conjugate, CST) at 4C for 2 hr. Similar
procedures as described in coimmunoprecipitation were conducted to detect
Akt or PLD proteins in the immune complexes.
Microscopy
Microscopy observation followed the standard protocols. Full details are in
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one table, seven figures, and Supple-
mental Experimental Procedures and can be found with this article at http://
dx.doi.org/10.1016/j.chom.2014.04.010.Cell HACKNOWLEDGMENTS
Thanks to Prof. Yi-Ping Wang of Peking University for providing Pseudomonas
strains and vectors; to Prof. Richard H. ffrench-Constant of University of Exeter
for critical review; and to Dr. Candong Wei, Dr. Bei Wang, and Dr. Tingting Zou
for technical advice. G.Y. was supported by the Scientific Research Founda-
tion for the Returned Overseas Chinese Scholars, SEM; and by PUMC Youth
Fund and the Fundamental Research Funds for the Central Universities.
Received: November 20, 2013
Revised: January 28, 2014
Accepted: March 21, 2014
Published: May 14, 2014
REFERENCES
Allen, L.A., Allgood, J.A., Han, X., andWittine, L.M. (2005). Phosphoinositide3-
kinase regulates actin polymerization during delayed phagocytosis of
Helicobacter pylori. J. Leukoc. Biol. 78, 220–230.
Alvarez-Ortega, C., and Harwood, C.S. (2007). Responses of Pseudomonas
aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is
by aerobic respiration. Mol. Microbiol. 65, 153–165.
Barret, M., Egan, F., Fargier, E., Morrissey, J.P., and O’Gara, F. (2011).
Genomic analysis of the type VI secretion systems in Pseudomonas spp.:
novel clusters and putative effectors uncovered. Microbiology 157, 1726–
1739.
Basler, M., Pilhofer, M., Henderson, G.P., Jensen, G.J., and Mekalanos, J.J.
(2012). Type VI secretion requires a dynamic contractile phage tail-like struc-
ture. Nature 483, 182–186.
Bingle, L.E., Bailey, C.M., and Pallen, M.J. (2008). Type VI secretion: a begin-
ner’s guide. Curr. Opin. Microbiol. 11, 3–8.
Boyer, F., Fichant, G., Berthod, J., Vandenbrouck, Y., and Attree, I. (2009).
Dissecting the bacterial type VI secretion system by a genome wide in silico
analysis: what can be learned from available microbial genomic resources?
BMC Genomics 10, 104.
Chin, Y.R., and Toker, A. (2010a). The actin-bundling protein palladin is an
Akt1-specific substrate that regulates breast cancer cell migration. Mol. Cell
38, 333–344.
Chin, Y.R., and Toker, A. (2010b). Akt2 regulates expression of the actin-
bundling protein palladin. FEBS Lett. 584, 4769–4774.
Dean, P. (2011). Functional domains and motifs of bacterial type III effector
proteins and their roles in infection. FEMS Microbiol. Rev. 35, 1100–1125.
Dong, T.G., Ho, B.T., Yoder-Himes, D.R., and Mekalanos, J.J. (2013).
Identification of T6SS-dependent effector and immunity proteins by Tn-seq
in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 110, 2623–2628.
Do¨tsch, A., Eckweiler, D., Schniederjans, M., Zimmermann, A., Jensen, V.,
Scharfe, M., Geffers, R., and Ha¨ussler, S. (2012). The Pseudomonas aerugi-
nosa transcriptome in planktonic cultures and static biofilms using RNA
sequencing. PLoS ONE 7, e31092.
Edwards, J.L., and Apicella, M.A. (2006). Neisseria gonorrhoeae PLD directly
interacts with Akt kinase upon infection of primary, human, cervical epithelial
cells. Cell. Microbiol. 8, 1253–1271.
Engel, J., and Eran, Y. (2011). Subversion of mucosal barrier polarity by pseu-
domonas aeruginosa. Front. Microbiol. 2, 114.
Gala´n, J.E. (2009). Common themes in the design and function of bacterial
effectors. Cell Host Microbe 5, 571–579.
Goluszko, P., Popov, V.,Wen, J., Jones, A., and Yallampalli, C. (2008). Group B
streptococcus exploits lipid rafts and phosphoinositide 3-kinase/Akt signaling
pathway to invade human endometrial cells. Am. J. Obstet. Gynecol. 199,
e541–e549.
Hood, R.D., Singh, P., Hsu, F., Gu¨vener, T., Carl, M.A., Trinidad, R.R.,
Silverman, J.M., Ohlson, B.B., Hicks, K.G., Plemel, R.L., et al. (2010). A type
VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria.
Cell Host Microbe 7, 25–37.ost & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier Inc. 609
Cell Host & Microbe
A T6S PLD Protein Is Trans-Kingdom EffectorIzore´, T., Job, V., and Dessen, A. (2011). Biogenesis, regulation, and targeting
of the type III secretion system. Structure 19, 603–612.
Jacobs, A.C., Hood, I., Boyd, K.L., Olson, P.D., Morrison, J.M., Carson, S.,
Sayood, K., Iwen, P.C., Skaar, E.P., and Dunman, P.M. (2010). Inactivation
of phospholipase D diminishes Acinetobacter baumannii pathogenesis.
Infect. Immun. 78, 1952–1962.
Jani, A.J., and Cotter, P.A. (2010). Type VI secretion: not just for pathogenesis
anymore. Cell Host Microbe 8, 2–6.
Kierbel, A., Gassama-Diagne, A., Mostov, K., and Engel, J.N. (2005). The phos-
phoinositol-3-kinase-protein kinaseB/Akt pathway is critical for Pseudomonas
aeruginosa strain PAK internalization. Mol. Biol. Cell 16, 2577–2585.
Kierbel, A., Gassama-Diagne, A., Rocha, C., Radoshevich, L., Olson, J.,
Mostov, K., and Engel, J. (2007). Pseudomonas aeruginosa exploits a PIP3-
dependent pathway to transform apical into basolateral membrane. J. Cell
Biol. 177, 21–27.
Koskiniemi, S., Lamoureux, J.G., Nikolakakis, K.C., t’Kint de Roodenbeke, C.,
Kaplan, M.D., Low, D.A., and Hayes, C.S. (2013). Rhs proteins from diverse
bacteria mediate intercellular competition. Proc. Natl. Acad. Sci. USA 110,
7032–7037.
Krachler, A.M., Woolery, A.R., and Orth, K. (2011). Manipulation of kinase
signaling by bacterial pathogens. J. Cell Biol. 195, 1083–1092.
Lesic, B., Starkey, M., He, J., Hazan, R., and Rahme, L.G. (2009). Quorum
sensing differentially regulates Pseudomonas aeruginosa type VI secretion
locus I and homologous loci II and III, which are required for pathogenesis.
Microbiology 155, 2845–2855.
Li, M., Le Trong, I., Carl, M.A., Larson, E.T., Chou, S., De Leon, J.A., Dove, S.L.,
Stenkamp, R.E., and Mougous, J.D. (2012). Structural basis for type VI secre-
tion effector recognition by a cognate immunity protein. PLoS Pathog. 8,
e1002613.
Lin, J.S., Ma, L.S., and Lai, E.M. (2013). Systematic dissection of the agrobac-
terium type VI secretion system reveals machinery and secreted components
for subcomplex formation. PLoS ONE 8, e67647.
Ma, A.T., McAuley, S., Pukatzki, S., and Mekalanos, J.J. (2009). Translocation
of a Vibrio cholerae type VI secretion effector requires bacterial endocytosis by
host cells. Cell Host Microbe 5, 234–243.
Mougous, J.D., Cuff, M.E., Raunser, S., Shen, A., Zhou, M., Gifford, C.A.,
Goodman, A.L., Joachimiak, G., Ordon˜ez, C.L., Lory, S., et al. (2006). A
virulence locus of Pseudomonas aeruginosa encodes a protein secretion
apparatus. Science 312, 1526–1530.
Pukatzki, S., Ma, A.T., Sturtevant, D., Krastins, B., Sarracino, D., Nelson, W.C.,
Heidelberg, J.F., and Mekalanos, J.J. (2006). Identification of a conserved
bacterial protein secretion system in Vibrio cholerae using the Dictyostelium
host model system. Proc. Natl. Acad. Sci. USA 103, 1528–1533.610 Cell Host & Microbe 15, 600–610, May 14, 2014 ª2014 Elsevier IRudolph, A.E., Stuckey, J.A., Zhao, Y., Matthews, H.R., Patton,W.A., Moss, J.,
and Dixon, J.E. (1999). Expression, characterization, and mutagenesis of
the Yersinia pestis murine toxin, a phospholipase D superfamily member.
J. Biol. Chem. 274, 11824–11831.
Russell, A.B., Hood, R.D., Bui, N.K., LeRoux, M., Vollmer, W., and Mougous,
J.D. (2011). Type VI secretion delivers bacteriolytic effectors to target cells.
Nature 475, 343–347.
Russell, A.B., LeRoux, M., Hathazi, K., Agnello, D.M., Ishikawa, T., Wiggins,
P.A., Wai, S.N., and Mougous, J.D. (2013). Diverse type VI secretion phospho-
lipases are functionally plastic antibacterial effectors. Nature 496, 508–512.
Sana, T.G., Hachani, A., Bucior, I., Soscia, C., Garvis, S., Termine, E., Engel, J.,
Filloux, A., and Bleves, S. (2012). The second type VI secretion system
of Pseudomonas aeruginosa strain PAO1 is regulated by quorum sensing
and Fur and modulates internalization in epithelial cells. J. Biol. Chem. 287,
27095–27105.
Selvy,P.E., Lavieri, R.R., Lindsley,C.W.,andBrown,H.A. (2011).Phospholipase
D: enzymology, functionality, and chemical modulation. Chem. Rev. 111, 6064–
6119.
Shneider, M.M., Buth, S.A., Ho, B.T., Basler, M., Mekalanos, J.J., and Leiman,
P.G. (2013). PAAR-repeat proteins sharpen and diversify the type VI secretion
system spike. Nature 500, 350–353.
Sibley, C.D., Rabin, H., and Surette, M.G. (2006). Cystic fibrosis: a polymicro-
bial infectious disease. Future Microbiol. 1, 53–61.
Sidhu, G., Li, W., Laryngakis, N., Bishai, E., Balla, T., and Southwick, F. (2005).
Phosphoinositide 3-kinase is required for intracellular Listeria monocytogenes
actin-based motility and filopod formation. J. Biol. Chem. 280, 11379–11386.
Silverman, J.M., Agnello, D.M., Zheng, H., Andrews, B.T., Li, M., Catalano,
C.E., Gonen, T., and Mougous, J.D. (2013). Haemolysin coregulated protein
is an exported receptor and chaperone of type VI secretion substrates. Mol.
Cell 51, 584–593.
Singh, P.K., Schaefer, A.L., Parsek, M.R., Moninger, T.O., Welsh, M.J., and
Greenberg, E.P. (2000). Quorum-sensing signals indicate that cystic fibrosis
lungs are infected with bacterial biofilms. Nature 407, 762–764.
Toschi, A., Lee, E., Xu, L., Garcia, A., Gadir, N., and Foster, D.A. (2009).
Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic
acid: competition with rapamycin. Mol. Cell. Biol. 29, 1411–1420.
Wilderman, P.J., Vasil, A.I., Johnson, Z., and Vasil, M.L. (2001). Genetic and
biochemical analyses of a eukaryotic-like phospholipase D of Pseudomonas
aeruginosa suggest horizontal acquisition and a role for persistence in a
chronic pulmonary infection model. Mol. Microbiol. 39, 291–303.
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K.C.,
Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002). Effects of reduced
mucus oxygen concentration in airway Pseudomonas infections of cystic
fibrosis patients. J. Clin. Invest. 109, 317–325.nc.
